Syros Pharmaceuticals, Inc. - Common Stock (SYRS)
0.1774
0.00 (0.00%)
Syros Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies for the treatment of cancer and other serious diseases through the manipulation of gene regulation
The company leverages its proprietary technology platform to identify and develop small molecules that target specific genes and cellular pathways, aiming to disrupt the disease process at the molecular level. Syros is dedicated to advancing its pipeline of product candidates, which are designed to selectively modulate gene expression and provide new treatment options for patients with unmet medical needs. Through its research and development efforts, Syros aims to improve patient outcomes and ultimately transform the landscape of disease management.
Frequently Asked Questions
Is Syros Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Syros Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Syros Pharmaceuticals, Inc. - Common Stock trade on?
Syros Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Syros Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Syros Pharmaceuticals, Inc. - Common Stock is SYRS on the Nasdaq Stock Market
What is the current price of Syros Pharmaceuticals, Inc. - Common Stock?
The current price of Syros Pharmaceuticals, Inc. - Common Stock is 0.1774
When was Syros Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Syros Pharmaceuticals, Inc. - Common Stock was at 4:00 pm EST on February 5th, 2025
What is the market capitalization of Syros Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Syros Pharmaceuticals, Inc. - Common Stock is 3.65M
How many shares of Syros Pharmaceuticals, Inc. - Common Stock are outstanding?
Syros Pharmaceuticals, Inc. - Common Stock has 20.60M shares outstanding.